JCB Laboratories recalls ophthalmic injection solution due to subpotent drug risk
JCB Laboratories recalls specific ophthalmic injection solutions that may be subpotent before their 90-day beyond use date, posing a risk of ineffective treatment.
Lower-risk recall
Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.
Contact the company
What happened, in plain English
JCB Laboratories is recalling certain ophthalmic injection solutions that may be less potent than intended before their 90-day beyond use date. This could lead to ineffective treatment if used as prescribed. Read more at govinfonow.com/recall/40909-jcb-laboratories-recalls-ophthalmic-injection-solution-due-to-subpotent-drug.
Source Summary by GovInfoNow · govinfonow.com/recall/40909-jcb-laboratories-recalls-ophthalmic-injection-solution-due-to-subpotent-drug · Updated October 7, 2026 · FDA enforcement record: FDA #D-0246-2018
Cite this page
“JCB Laboratories recalls ophthalmic injection solution due to subpotent drug risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40909-jcb-laboratories-recalls-ophthalmic-injection-solution-due-to-subpotent-drug. Based on FDA recall #D-0246-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0246-2018%22&limit=1).
Why it’s dangerous
The product may be less potent than intended before its 90-day beyond use date. This means the medication might not work as effectively for treating eye infections or other conditions.
Who’s affected
Healthcare professionals and hospitals using the recalled ophthalmic injection solutions. Patients receiving treatment with these specific solutions are at risk of ineffective therapy.
How to tell if you have this one
Check for the lot numbers C274-000002725, C274-000002790, C274-000002989, C274-000003008, or C274-000003077 with the specified beyond use dates.
- Brand
JCB Laboratories- Category
Drug
What to do — step by step
Check Product Lot Number
Look for the lot numbers listed in the recall notice: C274-000002725, C274-000002790, C274-000002989, C274-000003008, or C274-000003077.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
Check the product lot number against the list provided in the recall notice. If it matches, contact JCB Laboratories for further instructions.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0246-2018 (January 24, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0246-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.